Matthew D. Rutter
About
In The Last Decade
Matthew D. Rutter
133 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 5.0k
- Genetics 4.0k
- Surgery 3.2k
- Pulmonary and Respiratory Medicine 3.2k
- Epidemiology 2.8k
Countries citing papers authored by Matthew D. Rutter
This map shows the geographic impact of Matthew D. Rutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Rutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Rutter more than expected).
Fields of papers citing papers by Matthew D. Rutter
This network shows the impact of papers produced by Matthew D. Rutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Rutter. The network helps show where Matthew D. Rutter may publish in the future.
Co-authorship network of co-authors of Matthew D. Rutter
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Rutter. A scholar is included among the top collaborators of Matthew D. Rutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Rutter. Matthew D. Rutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 24 | |
| 3 | 7 | |
| 4 | 19 | |
| 5 | 9 | |
| 6 | 95 | |
| 7 | Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) breakdown → | 255 |
| 8 | 98 | |
| 9 | 129 | |
| 10 | 77 | |
| 11 | 1 | |
| 12 | 0 | |
| 13 | USING A "CONVERSION FACTOR" TO ESTIMATE ADENOMA DETECTION RATE | 4 |
| 14 | 3 | |
| 15 | 0 | |
| 16 | 1 | |
| 17 | 5 | |
| 18 | Cultural adaptation of the Hyperglycaemia Avoidance Scale (HAS) for use in the UK and modifications to improve suitability for insulin pump and continuous glucose monitoring users | 2 |
| 19 | 0 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.